Emergency Contraceptive Pills Market

Global Market Study on Emergency Contraceptive Pills: Combination Pills to Account for Leading Revenue Share during 2017-2022

Emergency Contraceptive Pills Market Segmented By Combination Pills, Progesterone Pills, Estrogen Pills Product

  • September-2017
  • PMRREP18343
  • 170 Pages
  • Healthcare


Apropos this report, global sales of emergency contraceptive pills are likely to witness dwindling growth over the span of next five years. During the forecast period, 2017-2022, the global market for emergency contraceptive pills is expected to incur a listless growth, reaching a value of over US$ 1,230 Mn.

From time constraints associated to the intake of emergency contraceptive pills to their side-effects, several factors are expected to hamper the sales of emergency contraceptive pills over the forecast period.

The report projects North America as the largest market for emergency contraceptive pills. US-based organizations such as the International Consortium for Emergency Contraception, a body that aims to expand access to proper emergency contraception products, are expected to promote the use of emergency contraceptive pills.

Urban cultures across developed and developing markets such as Europe and Asia-Pacific excluding Japan (APEJ) are showcasing the rise in mutual consent of partners towards unprotected sex. Although, unprotected coitus fuels the risks of sexually transmitted infections, and emergency contraceptive pills are unable to offer protection against venereal diseases, which further negates their status in terms of adoption.

emergency contraceptive pills market

Find Out More about the Report Coverage


Company Profile

  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG, HRA Pharma
  • Piramal Enterprises Limited
  • Mankind Pharma Ltd.
  • Richter Gedeon Nyrt
  • Lupin Limited
  • Cooper Pharma
  • Pfizer Inc.
  • Zhejiang Xianju Pharmaceutical Co.
  • Others

Sales of Combination Pills to Incur Relatively Steady Gains

Products offered in the global emergency contraceptive pills market hold variable as well as similar functionalities. However, the effectiveness of these products, coupled with inclination to pills with least side effects, serves as the criteria for purchases. Combined oral contraceptives, also known as combination pills, are effective in reducing the risks of ectopic pregnancy, ovarian cancer, as well as the incidence of iron deficiencies in a state of premenstrual tension. In 2017, global sales of combination pills are pegged to hold around 40% share on global revenues.

The demand for estrogen pills, on the other hand, will be declining at a faster rate over the forecast period. By the end of 2022, progesterone pills will also lose traction in their use for emergency contraception. Breast pain, hot flashes, diarrhea, and joint pain are some of the side effects associated with consumption of progesterone pills, which are expected to lower the sales in the global emergency contraceptive pills market.

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Online Traders to Record Low Sales

On the basis of sales channel, growth of the global emergency contraceptive pills market will remain concentered to revenues procured from hospital pharmacies and drug stores. With the latter being the largest sales channel, emergency contraceptive pills sold through hospital pharmacies and drug stores are expected to collectively account for more than three-fifth share on global revenues.

Online sales of emergency contraceptive pills, on the contrary, will lose traction in 2017 and beyond. Despite the robust penetration of e-commerce platforms across the global sales network for emergency contraception products, the 72-hous time constraint on intake of emergency contraceptive pills is expected to factor their online sales.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Emergency Contraceptive Pills – Manufacturing Overview

The report has also profiled leading players in the global market for emergency contraceptive pills. Companies such as Bayer AG, Teva Pharmaceutical Industries Ltd., Piramal Enterprises Limited, HRA Pharma, Mankind Pharma Ltd., Lupin Limited, Richter Gedeon Nyrt, Cooper Pharma, Zhejiang Xianju Pharmaceutical Co., and Pfizer Inc. are expected to be active in the global expansion of emergency contraceptive pills market. Manufacturers of emergency contraceptive pills are expected to put more R&D into development of pills with minimum side effects.

Explore Persistence Market Research’s expertise in promulgation of the business !

Market Segmentation

After offering a formal introduction to the global emergency contraceptive pills market, the report reveals the market taxonomy as per the table below. For the purpose of analysis and forecast, the global market for emergency contraceptive pills has been segmented on the basis of product-types, sales channels, and region. These segments are further categorized to broaden the taxonomy and provide intrinsic analysis.

  • North Americ
  • Latin America
  • Europe
  • Japan
  • APEJ
  • MEA
Product Type
  • Combination Pills
  • Progesterone Pills
  • Estrogen Pills
  • Other Products
Sales Channel
  • Drug Stores/ Pharmacy
  • Hospital Pharmacies
  • Online Traders
  • Other Channels

Media Release


Biologics Contract Manufacturing Demand

PMR’s study on biologics contract manufacturing demand offers information divided into five important segments— product, platform, application, therapeutic area & regional outlook.

Human Insulin Market

The global human insulin market is slated to reach US$ 44 Bn in the year 2022 and reach US$ 70.68 Bn at a CAGR of 8% between 2022 and 2028..

Global Biological Drugs Market

PMR study report indicates that the global biological drugs market will witness a healthy CAGR of over 10% during the forecast period to reach US$ 287,139.7 by 2021.

Uveitis Treatment Market

Uveitis treatment drug manufacturers are concentrating on developing technologically advanced products as well as novel drug formulations that can reduce uveitis and allow the ophthalmologist to offer to improve ophthalmic treatment and patient care..

Our Clients

Our Clients